Mizuho Analysts Trim Price Target for Evolus Following Strategic Market Assessment
Investment bank Mizuho recently revised its financial outlook for Evolus, Inc., a medical aesthetics company that has become a significant player in
by 
Josh Weiner
Josh Weiner